Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)

ClinicalTrials.gov ID: NCT00048516

Public ClinicalTrials.gov record NCT00048516. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 5:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to determine whether paricalcitol is safe and effective compared to placebo in reducing elevated serum PTH levels in patients with chronic kidney disease.

Study identification

NCT ID
NCT00048516
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
68 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2002
Primary completion
Not listed
Completion
Not listed
Last update posted
Aug 1, 2006

Started 2002

United States locations

U.S. sites
16
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
VA Greater Los Angeles Healthcare System, West Los Angeles Los Angeles California 90073
Nephrology Associates Medical Group Riverside California 92501
Kidney Center, Inc. Simi Valley California 93065
Denver Nephrologists Denver Colorado 80220
University of CO Health Sciences Center Denver Colorado 80262
Dialysis PC Des Moines Iowa 50309
Twin Cities Clinical Research Arden Hills Minnesota 55126
Long Island College Hospital Brooklyn New York 11201
Erie County Medical Center Buffalo New York 14215
Temple University Hospital Philadelphia Pennsylvania 19140
Medical University of South Carolina Charleston South Carolina 29425
Avera McKennan Research Institute Sioux Falls South Dakota 57105
Nephrology Associates Nashville Tennessee 37205
San Antonio Kidney Disease Research Center San Antonio Texas 78219
Clinical Research Associates of Tidewater Norfolk Virginia 23507
FHS Research Center Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00048516, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 1, 2006 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00048516 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →